Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Hair loss in men is common, treatable, but not curable.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Lowering testosterone speeds up wound healing in male mice.

Oxidative stress affects hair loss in men with androgenetic alopecia.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Stem cells from hair follicles can safely treat hair loss.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

PRP treatment may increase hair density and reduce hair loss, but more research is needed.

PRP treatment may stimulate hair growth by promoting blood vessel formation, increasing growth factors, and preventing cell death.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

DHT, a testosterone byproduct, causes male pattern baldness.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Reduced AR gene methylation may cause early pubic hair growth in girls.